Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour first day on Wegovy begins with a 0.25 mg dose — the lowest available — and for most people, not a great deal happens straight away. The medicine is a prescription-only semaglutide injection, and the starter dose is designed to let your body adjust rather than to produce immediate weight loss. Here is a clear, factual account of what to expect in the hours after that first injection, drawn from the NHS semaglutide guidance and clinical evidence, so you can go into day one feeling informed rather than anxious.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Pull your Wegovy pen from the fridge and let it sit at room temperature for around 15 to 30 minutes. A cold injection is not dangerous, but it is more comfortable when the liquid has warmed slightly. While you wait, glance at the liquid through the pen window: it should be clear or faintly yellow, with no floating particles. If it looks cloudy or discoloured, do not use that pen, contact your prescriber instead. That quick visual check is a habit worth building from day one.
Choose your injection site: abdomen (at least five centimetres from the navel), outer thigh, or upper arm. Clean the area with an alcohol swab and let it dry. Remove the pen cap, press the pen firmly against your skin at 90 degrees, and press the button until you hear a click. Hold it there for ten seconds before removing. The full Wegovy overview on our treatment page covers injection technique in more detail if you want to review it before you begin.
For many people, the first few hours after the 0.25 mg dose pass without incident. Some notice mild nausea, usually starting one to three hours post-injection and lasting a few hours; others feel nothing at all. Fatigue, a slight headache, or a vague feeling of fullness are also reported, but these are far from universal at the starter dose.
The mechanism behind any nausea is well understood: semaglutide activates GLP-1 receptors in the gut and brain, slowing gastric emptying and influencing signals in the area of the brain that controls nausea. That is, in a sense, the medicine working, but the 0.25 mg dose is calibrated precisely to keep that response modest. If you do feel queasy, eating small, plain meals, staying upright after eating, and drinking water steadily through the day tends to help. Ginger is a practical option too. Our dedicated day-one guide includes practical meal ideas for those first hours.
One thing the first injection will not do is noticeably reduce your hunger. Appetite suppression builds gradually over the weeks of treatment, not within a single day.
You do not need to rearrange your day around the injection. Most people carry on normally. What is worth doing is taking a note of anything you feel (and when) so that you and your prescriber have something concrete to work from when your next clinical review comes around. A few lines in your phone's notes app is enough.
Keep an eye on injection-site reactions: minor redness or swelling at the site is common and short-lived. If you notice a larger raised lump that does not settle within a day, let your clinical team know.
Seek medical attention promptly if you experience severe or persistent stomach pain that radiates to your back, with or without vomiting. That pattern can indicate acute pancreatitis, which the MHRA flagged in a January 2026 Drug Safety Update for GLP-1 medicines. It is uncommon, particularly at the starter dose, but worth knowing about. If something feels seriously wrong, dial 111 or attend A&E, do not wait to contact your prescriber.
By the end of day one, the most useful thing you can do is decide on your weekly injection day and put a recurring reminder in your calendar. Consistency matters: semaglutide's half-life means that injecting on the same day each week keeps blood levels stable. You can shift the day by a day or two if you need to (your Patient Information Leaflet covers the details) but picking a day that suits your routine from the start makes it easier to stick to.
You will stay on 0.25 mg for four weeks before moving to the next dose level. What that first month looks like in practice is covered in our guide to the first month on Wegovy. Meanwhile, our first week on Wegovy piece picks up exactly where this page leaves off, tracking how side effects and appetite signals tend to evolve across those seven days, and if you want to look further ahead, our guide to day two on Wegovy covers what to expect when you wake up the morning after your first injection.
A note on costs, since it comes up: if you are trying to understand what private treatment involves financially, our Wegovy pricing guide explains what a legitimate private prescription typically includes and why the headline number alone rarely tells the full story.
Wegovy is a prescription-only medicine. Before your first injection, a clinical consultation with a GPhC-registered prescriber will have confirmed it is right for you, that assessment matters at every stage, not just at the start. If questions come up as treatment progresses, our prescribers are reachable seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.